3.0.0 621 2022-11-15T16:32:58Z 2022-11-15T16:32:58Z Senate S S 2013-03-20 113 ssju00 Judiciary Committee Senate Standing Referred to 2013-03-20T17:49:59Z To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. 113 1285 HR 2013-04-15 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations. Related bill CRS 2013-03-20 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2013-03-20 Introduced in Senate IntroReferral 10000 9 Library of Congress M001183 Sen. Manchin, Joe, III [D-WV] Joseph Manchin D WV N K000360 Sen. Kirk, Mark Steven [R-IL] MARK KIRK R IL STEVEN 2013-03-20 True F000062 Sen. Feinstein, Dianne [D-CA] Dianne Feinstein D CA 2013-03-20 True R000361 Sen. Rockefeller, John D., IV [D-WV] JAY ROCKEFELLER D WV 2013-03-20 True G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2013-03-20 True S000148 Sen. Schumer, Charles E. [D-NY] Charles Schumer D NY E. 2013-03-20 True N000032 Sen. Nelson, Bill [D-FL] CLARENCE NELSON D FL WILLIAM 2013-04-18 False R000595 Sen. Rubio, Marco [R-FL] Marco Rubio R FL 2013-04-18 False K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN 2013-07-29 False H000206 Sen. Harkin, Tom [D-IA] THOMAS HARKIN D IA RICHARD 2013-10-16 False Crime and Law Enforcement Drug trafficking and controlled substances Health care coverage and access Long-term, rehabilitative, and terminal care Prescription drugs Rural conditions and development Crime and Law Enforcement 00 2013-03-20 Introduced in Senate 2013-05-14T21:15:41Z Safe Prescribing Act of 2013 - Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone combination products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date of enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

]]> Safe Prescribing Act of 2013 Display Title Safe Prescribing Act of 2013 Short Titles as Introduced Safe Prescribing Act of 2013 Official Title as Introduced A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. Introduced in Senate 2013-03-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113s621is/xml/BILLS-113s621is.xml 2013-03-20 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.